Medikamentöse Prävention von kognitiver Verschlechterung und Demenz-Reference-Cited by-同舟云学术

Medikamentöse Prävention von kognitiver Verschlechterung und Demenz

Published:2020-03-17 Issue:5 Volume:63 Page:506-511
ISSN:1436-9990
Container-title:Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
language:de
Short-container-title:Bundesgesundheitsbl

Author:

Jessen Frank

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Link

http://link.springer.com/content/pdf/10.1007/s00103-020-03120-z.pdf

Reference41 articles.

1. Statista (2020) Bevölkerung – Zahl der Einwohner in Deutschland nach Altersgruppen am 31. Dezember 2018. https://de.statista.com/statistik/daten/studie/1365/umfrage/bevoelkerung-deutschlands-nach-altersgruppen/. Zugegriffen: 11. Jan. 2020

2. MetLife Foundation (2011) Alzheimer’s survey. https://www.metlife.com/content/dam/microsites/about/corporate-profile/alzheimers-2011.pdf. Zugegriffen: 11. Jan. 2020

3. Howard R, McShane R, Lindesay J et al (2012) Donepezil and memantine for moderate-to-severe Alzheimer’s disease. N Engl J Med 366:893–903

4. Albert MS, DeKosky ST, Dickson D et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the national institute on aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:270–279

5. Mitchell AJ, Shiri-Feshki M (2009) Rate of progression of mild cognitive impairment to dementia—meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 119:252–265

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Menopausal hormone therapy and Alzheimer’s disease: A literature review;V.F.Snegirev Archives of Obstetrics and Gynecology;2024-04-10

2. Protocol: Prospective evaluation of feasibility, added value and satisfaction of remote digital self-assessment for mild cognitive impairment in routine care with the neotivCare app;BMJ Open;2024-03

3. Wissensbestände und Wissensquellen im Entscheidungsprozess zur Risikoprädiktion der Alzheimer-Demenz. Medizinische Expert*innen und andere epistemische Autoritäten;Schriften zu Gesundheit und Gesellschaft - Studies on Health and Society;2023

4. Association Between Low-Density Lipoprotein Cholesterol Levels, Statin Use, and Dementia in Patients followed in German General Practices;Journal of Alzheimer's Disease;2021-01-05